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Background and purpose   We have developed an individually 
designed,  uncemented  femoral  component  for  achievement  of 
improved strain distribution and fixation to the bone, to make 
uncemented stems more applicable in femurs of abnormal size 
and shape, and to improve the joint mechanics. Here we describe 
the design of the implant and present the results of a prospective 
clinical study with at least 7 years of follow-up. 
Patients and methods   The prostheses are produced by CAD-
CAM technique. The design of the stem is based on CT informa-
tion, and the neck design is based on the surgeon’s planning of the 
center of rotation, femoral head offset, and leg length correction. 
The first-generation stem produced before 2001 had a proximal 
HA coating and a sand-blasted distal part that was down-scaled 
to avoid contact with compact bone. The second-generation stem 
had a porous coating beneath the HA layer and the distal part of 
the stem was polished. 
The implant was used in 762 hips (614 patients) from 1995 until 
2009. 191 of these hips were followed for 7 years and 83 others 
were followed for 10 years, and these hips are included in the pres-
ent study. Mean age at surgery was 48 (20–65) years. Congenital 
dysplasia of the hip was the reason for osteoarthritis in 46% and 
57% of the hips in respective groups. Merle d’Aubigné score was 
recorded in 152 and 75  hips in the two groups. Prostheses fol-
lowed for 10 years, and almost all in the 7-year group, were first-
generation stems. 
Results   The 7- and 10-year cumulative revision rates were 
1.1% and 2.4%, respectively, with stem revision for any reason 
as endpoint. The clinical results were similar at 7 and 10 years, 
with Merle d’Aubigné scores of 17. Intraoperative trochanteric 
fissures occurred in 2 of the 191 operations (1.0%); both healed 
after wiring. In hips followed for 7 years, 2 periprosthetic frac-
tures occurred; exchange of the stem was necessary in both. One 
additional fracture occurred between 7 and 10 years, and it was 
treated successfully with osteosynthesis. The rate of dislocation 
was 1.6% and 2.4%, respectively. There was no radiographic loos-
ening at follow-up. 
Interpretation   Use of a custom femoral stem gives a reliable 
fixation and promising medium-term clinical results in femurs 
of normal and abnormal shape and dimension. The individual 
design, which enables optimized joint mechanics, gives a low risk 
of mechanical complications. 
 
Several research groups have been involved in the develop-
ment of uncemented customized femoral stems to optimize the 
fit of the stem to the femur and to optimize the joint mechan-
ics (Robertson et al. 1987, Aldinger et al. 1988, Bargar 1989, 
Mulier et al. 1989, Stuhlberg et al. 1989, Rubin et al. 1992).
In 1990, a research group at our institution was established 
with the aim of developing a custom femoral stem. Using indi-
vidual design, we aimed to improve the strain distribution and 
fixation to the bone in uncemented stems. We felt a particular 
need for individually shaped stems for use in hips with abnor-
mal size and shape of the proximal femur. During the fol-
lowing 5 years, several experimental studies were performed 
to develop customized femoral stems with optimal fit to the 
proximal  femur  based  on  CT  information  and  CAD-CAM 
technology. Furthermore, studies were carried out to docu-
ment the stability of the stem and also the strain shielding in 
the proximal femur following insertion of the stem in human 
cadaver femurs (Kvistad et al. 1994, Aamodt et al. 1999, 2001, 
2002). The custom femoral stem that was developed has now 
been in clinical use since 1995. 
The aim of this paper is to present the design process of the 
custom femoral stem. We also report the 7–10-year clinical 
results using this implant. 
Patients and methods 
Surgical planning
A CT scanning of the proximal femur and the pelvis is per-
formed according to a standard protocol. The distal part of 
the femur is included to determine the femoral neck antever-
sion. The digitized CT information is sent to the manufacturer 428  Acta Orthopaedica 2010; 81 (4): 427–435
(Scandinavian  Customized  Prostheses  (SCP),  Trondheim, 
Norway). The surgeon has to provide a special order form 
along with clinical information, using a web-based interface 
to  communicate  with  the  manufacturer.  The  manufacturer 
then performs computer-aided modeling of the stem, aiming at 
contact with compact bone proximal to a level that is approxi-
mately 2 cm below the lesser trochanter and with a gradu-
ally increased offset between the stem and the bone distal to 
that level. Compact bone has been defined as bone with a CT 
density of more than 600 HU (Aamodt et al. 1999). A scano-
gram of the pelvis and the proximal femur and also a digital 
template of the suggested stem design are sent to the surgeon 
over the internet. The surgeon has to approve the suggested 
contours of the stem. Furthermore, the surgeon determines the 
center of rotation to achieve adequate medial offset and leg 
length by use of a digital template on the scanogram (Figure 
1). The prosthesis is designed with a neck that gives a femo-
ral neck anteversion of 10 degrees after insertion, unless the 
surgeon decides otherwise. Finally, the prosthesis (Unique; 
SCP,  Trondheim,  Norway)  is  manufactured  using  3-axis 
CNC-machining. Stems designed before January 2001 were 
grit-blasted, and the proximal part of the stem was covered 
with HA only (CAM Implants, Leiden, the Netherlands) and 
sterilized by gamma technique (Gamma-Master BV, the Neth-
erlands). Since we experienced that the stems of this first gen-
eration were slightly oversized, which necessitated removal 
of much compact bone, particularly in wide femurs with thick 
cortical bone, the stems were downscaled slightly from Janu-
ary  2001.  The  surface  treatment  of  the  second-generation 
stems was also changed: the proximal part of the stem was 
covered with a porous layer on which a 50-µm HA layer was 
added, and the stem distal to the coated area was highly pol-
ished (Medical Group, France). 
The operation
All operations were performed in the lateral decubitus position 
with direct lateral approach. The planning documents from 
the manufacturer include information about the resection level 
Figure 1. A. CT scans of the proximal femur, with 
5-mm  distance  between  each  section.  B.  Digital 
template of the suggested stem design. C. Use of 
the template for determination of ideal medial fem-
oral head offset and leg length. Information about 
medial femoral offset and leg length correction is 
automatically shown during use of the template. 
(The arrows show the text box where this informa-
tion is given).   A
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of the femoral neck. Using a resection guide (Figure 2), the 
surgeon is able to reproduce the computer-planned resection 
accurately. The acetabular component chosen is then inserted 
following preparation of the acetabular cavity. An inclination 
of 45 degrees and anteversion of 10–20 degrees are intended. 
After preparing the femur with standard broaches according to 
the instructions from the manufacturer, the final preparation of 
the proximal femur is performed with 1 or 2 custom broaches. 
In cases with very compact bone, a broach that is somewhat 
smaller than the final one is used. A trial neck and head is then 
mounted on the final broach to determine an adequate neck 
length. The broach is then replaced with the custom femo-
ral stem and the joint is reduced following mounting of the 
chosen prosthetic head. 
The  acetabular  component  and  type  of  articulation  are 
chosen according to the preferences of the surgeon. Prophy-
lactic antibiotic with first-generation cephalosporin was given 
intravenously before surgery and at 8, 16, and 24 h postop-
eratively. LMWH was given subcutaneously for 2 weeks as 
thrombosis prophylaxis.
Patients and prosthetic components
762 custom prostheses had been implanted by December 31, 
2008. Of these, 191 had been followed for 7 years and 83 for 
10 years (Table 1). 60% of the custom stems were used in 
women. Mean age at operation was 48 (20–65) years. Pri-
mary osteoarthritis was seen in 30% of the hips; 46% of the 
hips were dysplastic, whereas various other disorders were 
the reason for development of osteoarthritis in the remaining 
24%. The percentage of primary osteoarthritis was consider-
ably lower in hips observed for 10 years than in hips observed 
for 7 years (Table 1). Abnormalities in the shape of the femur 
such as abnormal femoral neck anteversion were more fre-
quent in the group with 10 years of follow-up than in the group 
with only 7 years of follow-up (Table 2). 
The types of custom stems, femoral heads, and acetabu-
lar components are shown in Table 3. All hips of the 7- and 
10-year follow-up groups received a custom stem of the first 
generation except for 8 of the 7-year group. The majority of 
acetabular components were uncemented whereas most of the 
modular heads were ceramic. 
Preoperative protocol, postoperative follow-up
The preoperative protocol included clinical evaluation using 
the modified Merle-d’Aubigné score (d’Aubigné and Postel 
Figure 2. A. Adjustable resection guide. B. The prosthesis produced after the plan-
ning shown in Figure 1 has been inserted into the right femur. A custom prosthesis 
has also been implanted into the left femur.
  A   B
Table 1. Study samples
   
  7 years of  10 years of
  follow-up   follow-up
  (191 hips)    (83 hips) 
   n   %   n   % 
Mean age at operation (years)   48 (20–65)  46 (20–60)
Females   115   60   47   57
Males     76   39   36   44 
Primary osteoarthritis     58   30   16   19 
Hip dysplasia     88   46  47   57 
Legg-Calvé-Perthes disease     14   7   10   12 
Rheumatoid disease     16   8     5   6
Sequel. femoral neck fracture        3   2     1   1 
Avascular femoral head necrosis       7   4    2   2
Other disorders of the hip       5   3    2   2 430  Acta Orthopaedica 2010; 81 (4): 427–435
1954) in addition to the radiological investigation of the pelvis 
and both hips and the CT investigation.
The initial protocol included clinical and radiographic fol-
low-up 3 months, 6 months, 1 year, and 2, 3, 5, 7, 10, 13, 15, 
and 20 years postoperatively. Following 5 years’ experience 
with the prosthesis, the protocol was modified to exclude the 
follow-ups at 6 months and at 2 and 3 years. We also excluded 
a regular recording of the Merle d’Aubigné score at the 7-year 
control. Thus, detailed clinical information including clinical 
score was recorded for 152 of the 191 hips that were observed 
for 7 years; in 146 of these, a prosthesis of the first genera-
tion had been implanted. Furthermore, clinical scores were 
recorded in 75 of the 83 hips observed for 10 years since the 
femoral component had been changed in 2 hips due to peri-
prosthetic fractures; in 6 other patients clinical scores were 
not recorded since they were followed up at other institutions. 
However, all complications and reoperations were registered 
at the 7- and 10-year follow-ups. 
The  radiological  follow-up  included  investigation  of  the 
pelvis and the operated hips in all patients. 
Results
Complications and reoperations
In the series of 191 hips that were followed for 7 years, an 
intraoperative fissure occurred in the trochanter region in 2 hips 
(1.0%). In both hips, the fissure healed after wiring without 
loosening of the custom stem. A partial lesion to the sciatic 
nerve occurred in 4 patients (2.1%) and to the anterior gluteal 
nerve in one hip (1.0%). All nerve lesions were verified by neu-
rophysiological examination. Two of the sciatic nerve lesions 
recovered completely. Dislocation occurred in 3 hips (1.6%); 
all 3 became stable after closed reduction. No deep infections 
occurred. Deep venous thrombosis was diagnosed in 1.6%. 2 
patients (1.0%) sustained a femoral fracture by a fall accident.
In the 83 hips that were followed for 10 years, one addi-
tional fracture occurred. Thus, the total rate of fractures within 
this group was 3.6%. There were no radiological signs of loos-
ening in any of the fractures before the fracture occurred and 
bone ingrowth was found at the reoperations. 
Reasons for, type of, and number of reoperations are given 
in Table 4. In both of the fractures that occurred before 7 
years,  stem  replacement  had  to  be  performed  because  of 
extensive splitting of the periprosthetic bone. Since there were 
no revisions of the femoral stem other than those mentioned, 
the cumulative revision rate of the stems at 7 and 10 years was 
1.0% and 2.4%, respectively. The fracture that occurred after 
7 years was treated successfully with plate osteosynthesis. The 
liner had to be changed because of wear between 7 and 10 
years postoperatively in 4 of 76 hips where a Duraloc ace-
tabular component had been used. Two hips were explored 
because of pain, but without any positive findings.
Clinical scores
The mean values of Merle d’Aubigné preoperative pain score 
were equal in hips followed for 7 and 10 years (2.9). The same 
was true for the postoperative pain scores (5.7). The preop-
erative total scores improved from 9.6 to 17.2, and from 9.4 
to 17.0, respectively. Thus, there was equal improvement in 
score values in the two observation groups. Thigh pain was 
noted at one or more follow-ups in 12% of 146 hips of the first 
Table 2. Preoperative femoral neck anteversion
     
  7 years of  10 years of
   follow-up   follow-up
  (191 hips)    (83 hips)
Preoperative neck anteversion 
  mean   19.5°   20.7°
  range    -6° to 90°   -33° to 90°
Number of hips with 
  retroversion    8 (4%)     3 (4%)
  30° or more anteversion  40 (21%)   25 (30%)
  50° or more anteversion    9 (5%)     6 (7%)
Table 3. Acetabular and femoral components
   
  7 years of  10 years of
  follow-up  follow-up 
  (191 hips)    (83 hips)
   n   %  n   %
Femoral components     
  First generation   182   95  83   100 
  Second generation   8   4   0   0 
Femoral heads        
  Articul/eze    67   35   55   66
  Ziolox   65   34  26   31 
  Biolox forte   59   31    2   2 
Acetabular components      
  Duraloc  173   91  76   92
  Charnley   6   3    3   4
  Elite Plus Ogee    7   4    4   5
  Trilogy AB   5   3   0   0
Table 4. Reoperations
Reason for  Type of reoperation  7 years of   10 years of
reoperation    follow-up   follow-up
      (191 hips)    (83 hips)
 
Hip instability  Closed reduction  3   2 
  Change of acetabular 
     component  0  0
Femoral fracture  Osteosynthesis  0  1 
  Change of femoral 
     component  2   2 
Polyethylene wear  Change of liner  0  4 
Ectopic ossification  Removal  1   0
Pain  Surgical exploration  2   2 Acta Orthopaedica 2010; 81 (4): 427–435  431
generation, where a detailed registration of the clinical find-
ings was performed over a 7-year period. 
Radiographic findings
No aseptic loosening was seen in hips observed for 7 and 10 
years. Regarding the position of the implanted stems, they had 
usually ended in the planned position relative to the resection 
level of the femoral neck, or less than 3 mm higher. The maxi-
mum discrepancy was 5 mm. In very few cases, a slight varus 
or valgus position was seen. 
Clinical examples
Some examples of what can be achieved by using custom 
stems are shown in Figures 2–6. Figure 2B demonstrates the 
results after insertion of the prosthesis that was planned as 
illustrated in Figure 1. The image demonstrates the suitability 
of a custom stem in congenital dysplasia with a low disloca-
tion by making a prosthesis with a CCD-angle and neck length 
that give adequate medial femoral head offset and leg length 
(right hip). Figure 3 demonstrates a custom stem in a case of 
high dislocation of the hip. In this case, a shortening oste-
otomy of 2.5 cm was performed. The osteotomy was fixated 
with the prosthesis alone. The sections through the part of the 
femur to be removed were eliminated when the prosthesis was 
designed. Figure 4 demonstrates how a corrective osteotomy 
can be avoided by using a customized stem in severe deformi-
ties of the femur. Figure 5 shows that use of custom stems 
enables  adequate  medial  femoral  head  offset  despite  there 
being an extremely narrow intramedullary canal. In such a 
case, it might be difficult to achieve normalization of offset by 
a standard stem since extremely narrow standard stems have a 
short neck. Finally, Figure 6 shows custom stems in dwarfism.
Figure 3. A. Scanogram of the right femur in a case of femoral head necrosis with high dislocation of the hip. B. Radiograph after subtrochanteric 
resection osteotomy and insertion of the custom stem. The osteotomy has healed.
  A   B
Figure 4. A. Bilateral hip dysplasia with valgus deformities after earlier subtrochanteric osteotomies. B. Radiograph after insertion of custom 
femoral stems bilaterally.
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Discussion
We have shown that the use of a custom uncemented stem has 
a low complication rate. Fissures in the trochanteric region 
occurred in 1.0% of the hips. In studies of uncemented stan-
dard  stems,  the  incidence  of  this  complication  has  varied 
between  1.2%  and  8.8%  (Petit  2004,  Sanchez-Sotelo  and 
Cabanela 2004, Toni et al. 2004, Videlain 2004, Lerch et al. 
2007). It should be noted that the fissures that occurred in our 
series had no consequence for the final result. The low rate of 
femoral fractures (1.0% before 7 years) also shows that indi-
vidually shaped stems can be used without increasing the risk 
of fracture. 
Even after the slight downscaling of the largest stems, we 
occasionally  experienced  some  difficulties  in  bringing  the 
prosthesis down to the planned level without removing some 
compact cancellous bone. However, most of the stems have 
been adequately dimensioned and oversizing of a minority of 
the stems has not restrained the insertion of the stem or caused 
any other serious problems. We have abandoned the use of 
such a stem in only 3 out of more than 800 hips in which use 
of such a stem had been planned. In 1 hip, use of a custom 
stem had to be abandoned since it was impossible to reduce 
the joint because the planned lengthening had been too ambi-
tious. Furthermore, one prosthesis could not be used since the 
stem was undersized. Finally, in 1 case the custom prosthesis 
could not be implanted because of a surgical error during the 
reaming of the severely deformed upper end of the femur. 
The femoral fractures recorded in the groups of hips fol-
lowed for either 7 or 10 years were all caused by fall injuries. 
There was no indication that oversize of the stem had contrib-
uted to these fractures. Moreover, the 1.0% rate of fractures in 
Figure 5. Preoperative (A) and postoperative (B) images in a case of bilateral CDH with osteoarthritis. Note that adequate medial femoral offset 
has been obtained despite the extremely narrow intramedullary cavities. 
  B   A
Figure 6. Preoperative (A) and postoperative (B) images of a case of dwarfism treated with custom stems. On the left side, an intraoperative fis-
sure was treated with wires.
  A   BActa Orthopaedica 2010; 81 (4): 427–435  433
hips observed for 7 years and the 3.6% rate in hips followed 
for 10 years are not higher than figures reported after use of 
standard stems. Thus, Radl et al. (2000) found an incidence of 
5.5% in 134 hips at an average of 5.5 years after insertion of 
proximally HA-coated stems. In cemented stems, Cook et al. 
(2008) found an incidence of fractures of 0.8% in 6,458 hips 5 
years after operation and 3.5% at 10 years.
We  have  generally  experienced  that  use  of  individually 
designed femoral stems is a reliable method to restore ade-
quate medial femoral head offset. Furthermore, use of such 
components contributes to stability of the joint since a suitable 
femoral neck anteversion will be achieved. Thus, it is almost 
impossible to ream the cavity in a way that leads to a tor-
sional malposition of the prosthesis. When the custom broach 
is brought down into the femoral canal, it is forced into the 
correct position by the compact endocortical bone. This is in 
contrast to what sometimes happens during broaching before 
insertion of a standard stem. A severely deformed femur might 
in some cases force a standard broach into a malrotated posi-
tion, despite efforts made to avoid this. A considerable number 
of our patients had hips with a severely abnormal preoperative 
femoral anteversion due to congenital dysplasia. Despite this 
there was a relatively low dislocation rate, which may partly 
be due to the standardized femoral anteversion achieved with 
the custom technique. A dislocation rate of 1.6% after 7 years 
and 2.4% after 10 years is certainly low in series constituting 
a relatively high percentage of femurs with a highly increased   
preoperative  anteversion.  Also,  an  adequate  reconstruction 
of the length of the femoral neck, which can be achieved by 
using individually designed femoral components, might con-
tribute to good stability of the hip.
We have experienced that adequate correction of leg length 
discrepancy is easily achieved if the preoperative shortening is 
less than 3 cm. We have only experienced a deviation from the 
planned leg length of more than 5 mm in a few cases. If the 
leg length discrepancy is more than 3 cm, it is probably wise 
not to aim for a complete equalization of leg length due to the 
risk of nerve lesions.
In cases with a high dislocation of the hip, a prosthesis can 
be designed to stabilize the osteotomy after resection of a sub-
trochanteric segment. However, great care has to be taken to 
ensure that fixation with the prosthesis alone will be adequate. 
In some cases, additional plate fixation will be advisable. If 
necessary, the shortening osteotomy can be done distal to the 
prosthesis. In cases with low dislocation, a prosthesis with 
a moderately reduced CCD-angle can be designed to bring 
the head of the prosthesis down to the right anatomical level 
without doing a shortening osteotomy. In such cases, a care-
ful stress analysis must be performed by the manufacturing 
company to ensure that such a design will not include a risk of 
fatigue fracture of the neck of the prosthesis. 
Concerning  the  overall  medium-term  clinical  results,  the 
Merle d’Aubigné score at 7 years was excellent. However, 
despite  the  fact  that  the  results  were  similar  in  the  group 
observed for 10 years, it remains to be seen whether the long-
term results will be maintained. It also remains to be seen 
whether the clinical results after operations with stems of the 
second generation will be different from the results presented 
where a first-generation stem was used in nearly all hips. 
The incidence of thigh pain after treatment with the first-
generation custom stems (12%) shows that this type of pros-
thesis has not completely eliminated the thigh pain phenom-
enon. Thigh pain markedly influenced the function in only 2 
patients. In studies of uncemented standard stems with coat-
ings for bony ingrowth, rates of thigh pain have been reported 
varying from 0% (Kim 2008) to close to 40% (Weidenhielm 
et al. 1995). In custom stems, Argenson et al. (2004) found 
less thigh pain in fully coated stems than in stems with only 
proximal coating. However, it is difficult to compare the inci-
dence of thigh pain in various studies since the recording has 
not  been  standardized.Since  no  cases  of  aseptic  loosening 
were recorded at the 7- and 10-year follow-up, it appears that 
an individual design contributes to safe fixation of the stem. 
Similar findings have been reported from other groups using 
custom stems (Wettstein et al. 2005, Leali et al. 2006, Akbar 
et al. 2009). During the past 10–15 years, however, the rate of 
aseptic loosening has also been substantially reduced in stan-
dard uncemented stems. According to a report from the Nor-
wegian Arthroplasty Register (Hallan et al. 2007), all stems 
currently used in Norway perform excellently with survival of 
96–100% at 10 years, with revision because of aseptic loos-
ening as the endpoint. It can be argued that a registry study 
does not reveal aseptic loosening that has not led to revision 
surgery. However, there have been several reports indicating 
a total rate of aseptic loosening of between 0% and 5% after 
10 years or more of observation (Emerson 2004, Moskal et 
al. 2004, Parvizi et al. 2004, Videlain 2004, Capello et al. 
2006, Sharma and Brooks 2006, Yoon et al. 2008). Thus, it 
can hardly be argued that a customized stem should be taken 
into general use due to a safer fixation than that achieved with 
standard stems. However, it should be noticed that there was 
a considerable number of hips included in our study where a 
standard uncemented stem could not be used because of severe 
deformity of the upper femur. If an individually designed stem 
had not been available, a cemented stem would have had to be 
used in these hips—if necessary, combined with a corrective 
osteotomy.
A more favorable strain distribution to the proximal femur 
was found in in vitro studies when compared to a standard 
proximal coated stem (PCA stem) (Aamodt et al. 2001). It 
could therefore be expected that an individual design would 
contribute to more favorable bone remodeling. However, pre-
liminary results of comparative DEXA studies have not shown 
less bone atrophy in the custom stems. This might be explained 
by the fact that the surgical trauma itself is a major reason for 
the bone loss, and that the strain distribution is modified by 
the ingrowth of bone. Results of these DEXA studies will be 
published later. 434  Acta Orthopaedica 2010; 81 (4): 427–435
More liberal use of custom prostheses in hips with no major 
anatomical deformities, as seen during the last part of the pres-
ent study period, might give cause for concern regarding cost 
since such prostheses are more expensive than standard stems. 
However, if their use is restricted to hips where there is a rea-
sonable chance of improved results compared to what would 
be obtained using standard stems, the higher costs would be 
justified. 
 In summary, we have experienced that the use of custom 
uncemented stems is a reliable method to achieve adequate 
mechanics of the hip joint in terms of suitable medial femo-
ral head offset and femoral neck anteversion, combined with 
optimal  leg  length  correction.  Furthermore,  the  individual 
fitting of the stems makes it possible to insert the stem into 
severely deformed femurs, reducing the need for corrective 
osteotomies. Use of such stems gives reliable fixation and 
excellent  medium-term  clinical  results,  but  does  not  com-
pletely eliminate the risk of thigh pain following the use of 
uncemented stems. Custom stems are especially indicated in 
hips with abnormal size and geometry of the upper femur, but 
use of such stems might also be advantageous in hips without 
major deformities—particularly if the preoperative planning 
shows that it might be difficult to restore ideal biomechan-
ics of the joint with a standard technique. The preoperative 
planning, like the operative technique, is easy, and the use of 
custom stems does not carry any additional risks compared to 
standard stems.
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